Integra LifeSciences | IART - 税前利润



金融业
股票价格
USD
资产
USD 3.6B
现金及等价物
USD 235.05M
销售成本
USD 193.45M
流动资产
USD 1.16B
流动负债
USD 455.98M
债务
USD 2.01B
EBIT
USD 66.01M
EBITDA
USD 104.21M
员工
4.4K
EPS每股收益
USD 0.83
股本和储备
USD 1.04B
销售毛利
USD 217.1M
债务利息支出
USD 23.67M
利息收入
USD 4.98M
贷款资金
USD 1.86B
市值
USD 836.2M
净收入
USD -1.7M
营业费用
USD 368.92M
营业利润
USD 66.01M
普通股股本
USD 77.89M
PE价格收益
6.59
税前利润
USD -6.82M
销售收入
USD 434.9M
销售和管理费用
USD 156.45M
股票
USD 492.74M
贸易债权人
USD 95.73M
应收帐款人
USD 278.85M


税前利润 更改 日
Abbott USD 2.39B 27M 2026-03
AtriCure USD 2.36M 2.45M 2025-12
Baxter International USD 121M 12M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
CONMED USD 4.27M 25.65M 2025-09
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 300M 58.9M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
HeartBeam USD -5.25M 280K 2025-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 73.18M 29.8M 2025-09
Orthofix International USD -2.19M 20.07M 2025-12
Smith & Nephew USD 469M 70M 2025-12
Stryker USD 1.03B 13M 2025-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12